NYC Health + Hospitals has published a guide to help hospitals and health systems plan and train for emerging infectious disease threats, and customize their plans specific to their unique clinical, operational and financial needs. “All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders,” the guide states. “This document provides high-level planning guidance for a frontline hospital multidisciplinary team … to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment.” In a recent Readiness Advisory, AHA urged hospitals to become familiar with the U.S. Regional Treatment Network for Ebola and Other Special Pathogens and understand their facility’s designated role as part of the network.

Headline
Two individuals in Pennsylvania have died from measles, the Pennsylvania Department of Health announced Aug. 25. They are the first deaths from the disease in…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Headline
The AHA will make a donation to the Indiana Hospital Association in support of hospital personnel impacted by the recent flooding in Indiana caused by severe…
Headline
The 2027 AHA Rural Healthcare Leadership Conference will be held Jan. 31-Feb. 3 in Orlando, Fla. Join fellow rural hospital CEOs, senior executives, clinical…
Headline
President Trump signed an executive order Aug. 10 revamping the federal government’s recommended childhood vaccine schedule. The order divides immunizations…
Headline
The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva. The vaccine is manufactured by Moderna and was approved for…